News
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
Chatbots can get scary if you suspend your disbelief. But MJ Cocking didn’t — and wound up in a relationship that was ...
One woman turns to Reddit after she's been paying to store her boyfriend’s broken car for months. But after watching him ...
Stock indexes in the U.S. moved upward Wednesday as the gained 1.14%. Meanwhile, the increased 0.78%, and the rose 0.61%.
1d
Zacks.com on MSNHims & Hers Paves the Way for Global Digital Health Expansion
HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.
Carissa Lynn Lochbaum, 33, of Hickory, was sentenced to 6-8 years in prison and a $500,000 fine for trafficking fentanyl and ...
Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...
The Arts Council of Greater Baton Rouge will present His & Hers, a curated evening for couples, at 5:30 p.m. Saturday at the ...
McCracken also adds there’s plenty of livestock that were traveling in these temperatures, with some still on their way out ...
5d
Zacks.com on MSNHims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up. That said, a few analysts are still pretty optimistic. They ...
Analysts have provided Laboratory Corp with 8 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $276.5, suggesting a potential 9.69% upside.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results